We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Politics > As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis
As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis
Politics

As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis

Last updated: May 8, 2022 9:00 am
Editorial Board Published May 8, 2022
Share
SHARE
05dc covid diplo1 sub facebookJumbo

The cost to UNICEF of Paxlovid — including Pfizer’s insistence that UNICEF keep how much it pays confidential — remains a sticking point, said Dr. Philippe Duneton, who runs the therapeutics arm of the W.H.O. consortium. In announcing its “strong recommendation” for Paxlovid, the W.H.O. took the highly unusual step of publicly scolding Pfizer for a “lack of transparency,” which makes it difficult to know which countries have the drug and what they are paying.

“We need to have better visibility in terms of price,” Dr. Duneton said.

Manufacturers often prefer that the details of their sales agreements be secret so as not to weaken their hand with other potential buyers. Pfizer’s chief executive, Albert Bourla, reported last week that Paxlovid had been a “key growth driver” for the company, which is using a “tiered pricing approach” in which low- and lower-middle-income countries will get Paxlovid at a not-for-profit price.

In response to an inquiry from The New York Times, Pfizer issued a statement saying that it was “deeply disappointed by the sentiment expressed by our partners,” adding, “We have in good faith heard and responded to many of their concerns.”

Both Pfizer and Merck have also taken steps to make inexpensive generic versions of their pills available, signing licensing agreements with the Medicines Patent Pool, which was created during the global AIDS crisis to bring drugs to low- and middle-income nations at low cost. It took years, and bitter fights between activists and companies, to reach such agreements for H.I.V. drugs.

But the agreements for Covid antivirals do not apply to many middle-income nations, including much of Latin America and parts of northern Africa and Asia. The result, experts say, is that both poor and rich nations will have access, but countries in the middle will have to negotiate with the companies — or force the drugmakers to turn over their intellectual property.

So far, 36 companies from 12 countries have signed up to make generic Paxlovid. Companies in India are already making generic versions of both Paxlovid and molnupiravir. The expectation is that both drugs will ultimately be available in about 100 low- and middle-income countries, covering about half the world’s population. The companies will not receive royalties from the sales while the W.H.O.’s declaration of the pandemic as a global health emergency remains in effect.

“Given the severity of the pandemic and given the fact that vaccines had a very uneven penetration rate, we felt that this was a very important contribution the company could make,” said Paul Schaper, executive director for global public policy at Merck.

You Might Also Like

NYC Mayor Adams stories greatest fundraising haul since indictment

Republican Senate rolls again SALT cap to $10K in Trump price range invoice

NYC Mayor Adams addresses backlash over smoking cigars with antisemitic influencer Sneako

Trump: Immigration crackdown to give attention to NYC, different ‘crime-ridden inner cities’

Early voting in NYC’s 2025 elections greater than doubles 2021 turnout

TAGGED:Acquired Immune Deficiency SyndromeCoronavirus (2019-nCoV)Drugs (Pharmaceuticals)Income InequalityMolnupiravir (Drug)Paxlovid (Drug)Tests (Medical)The Washington MailUnited States International RelationsWorld Health Organization
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Native American sufferers are despatched to collections for money owed the federal government owes
Health

Native American sufferers are despatched to collections for money owed the federal government owes

Editorial Board December 29, 2024
Yankees’ Austin Wells newest Bomber battling meals poisoning
Smartphones might enhance accuracy of medical gadgets throughout pores and skin tones
Sam Waterston Is Still the Face of ‘Law & Order’
Golden Knights snap a 4-game skid with a 3-1 victory over Devils

You Might Also Like

FAA nominee reportedly lacks business pilot certification he claimed to have
Politics

FAA nominee reportedly lacks business pilot certification he claimed to have

June 16, 2025
LEONARD GREENE: ‘No Kings’ protesters rain on Trump’s navy parade
Politics

LEONARD GREENE: ‘No Kings’ protesters rain on Trump’s navy parade

June 15, 2025
The Military is ready to rejoice 250 years with a parade that coincides with Trump’s birthday
Politics

The Military is ready to rejoice 250 years with a parade that coincides with Trump’s birthday

June 14, 2025
Marines are seen standing guard at a federal constructing in Los Angeles
Politics

Marines are seen standing guard at a federal constructing in Los Angeles

June 13, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?